According to the enterprise survey app, recently, Shenzhen Hongxin Biotechnology Co., Ltd. underwent business changes, adding Guangxi Tencent Venture Capital Co., Ltd. and others as shareholders, while the registered capital increased to 2,557.39 million yuan. According to enterprise research information, the company was founded in 2021, and its business scope includes: biomass energy technology services; medical research and experimental development; cell technology research and application. According to its official website, Hongxin Biotech is an innovative RNA drug research and development company.

According to the enterprise survey app, recently, Shenzhen Hongxin Biotechnology Co., Ltd. underwent business changes, adding Guangxi Tencent Venture Capital Co., Ltd. and others as shareholders, while the registered capital increased to 2,557.39 million yuan. According to enterprise research information, the company was founded in 2021, and its business scope includes: biomass energy technology services; medical research and experimental development; cell technology research and application. According to its official website, Hongxin Biotech is an innovative RNA drug research and development company.